Macrophage Phenotype and Fibrosis in Diabetic Nephropathy

被引:211
作者
Calle, Priscila [1 ,2 ]
Hotter, Georgina [1 ]
机构
[1] Inst Invest Biomed August Pi & Sunyer IIBB CSIC I, Consejo Super Invest Cient, Inst Invest Biomed Barcelona, Dept Expt Pathol, Rossello 161,7th Floor, Barcelona 08036, Spain
[2] M2rlab XCELL, C Juan Bravo 10,Puerta 2, Madrid 28006, Spain
关键词
macrophages; diabetic nephropathy; fibrosis; MONOCYTE CHEMOATTRACTANT PROTEIN-1; TUMOR-NECROSIS-FACTOR; TNF RECEPTORS 1; RENAL INJURY; NLRP3; INFLAMMASOME; KIDNEY-DISEASE; MICE; URINARY; CONTRIBUTES; ACTIVATION;
D O I
10.3390/ijms21082806
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease globally. The primary initiating mechanism in DN is hyperglycemia-induced vascular dysfunction, but its progression is due to different pathological mechanisms, including oxidative stress, inflammatory cells infiltration, inflammation and fibrosis. Macrophages (M phi) accumulation in kidneys correlates strongly with serum creatinine, interstitial myofibroblast accumulation and interstitial fibrosis scores. However, whether or not M phi polarization is involved in the progression of DN has not been adequately defined. The prevalence of the different phenotypes during the course of DN, the existence of hybrid phenotypes and the plasticity of these cells depending of the environment have led to inconclusive results. In the same sense the role of the different macrophage phenotype in fibrosis associated or not to DN warrants additional investigation into M phi polarization and its role in fibrosis. Due to the association between fibrosis and the progressive decline of renal function in DN, and the role of the different phenotypes of M phi in fibrosis, in this review we examine the role of macrophage phenotype control in DN and highlight the potential factors contributing to phenotype change and injury or repair in DN.
引用
收藏
页数:14
相关论文
共 98 条
  • [21] Potential Role of Regulatory T Cells in Reversing Obesity-Linked Insulin Resistance and Diabetic Nephropathy
    Eller, Kathrin
    Kirsch, Alexander
    Wolf, Anna M.
    Sopper, Sieghart
    Tagwerker, Andrea
    Stanz, Ursula
    Wolf, Dominik
    Patsch, Wolfgang
    Rosenkranz, Alexander R.
    Eller, Philipp
    [J]. DIABETES, 2011, 60 (11) : 2954 - 2962
  • [22] Diverse origins of the myofibroblast -implications for kidney fibrosis
    Falke, Lucas L.
    Gholizadeh, Shima
    Goldschmeding, Roel
    Kok, Robbert J.
    Nguyen, Tri Q.
    [J]. NATURE REVIEWS NEPHROLOGY, 2015, 11 (04) : 233 - 244
  • [23] THE ROLE OF MACROPHAGES IN DIABETIC GLOMERULOSCLEROSIS
    FURUTA, T
    SAITO, T
    OOTAKA, T
    SOMA, J
    OBARA, K
    ABE, K
    YOSHINAGA, K
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (05) : 480 - 485
  • [24] Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy
    Gao, Qing
    Shen, Wenwen
    Qin, Weisong
    Zheng, Chunxia
    Zhang, Mingchao
    Zeng, Caihong
    Wang, Shengyu
    Wang, Jianping
    Zhu, Xiaodong
    Liu, Zhihong
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (11) : 3539 - 3547
  • [25] Advanced Oxidation Protein Products-Modified Albumin Induces Differentiation of RAW264.7 Macrophages into Dendritic-Like Cells Which Is Modulated by Cell Surface Thiols
    Garibaldi, Silvano
    Barisione, Chiara
    Marengo, Barbara
    Ameri, Pietro
    Brunelli, Claudio
    Balbi, Manrico
    Ghigliotti, Giorgio
    [J]. TOXINS, 2017, 9 (01):
  • [26] Tissue-Resident Macrophage Ontogeny and Homeostasis
    Ginhoux, Florent
    Guilliams, Martin
    [J]. IMMUNITY, 2016, 44 (03) : 439 - 449
  • [27] Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes
    Gohda, Tomohito
    Niewczas, Monika A.
    Ficociello, Linda H.
    Walker, William H.
    Skupien, Jan
    Rosetti, Florencia
    Cullere, Xavier
    Johnson, Amanda C.
    Crabtree, Gordon
    Smiles, Adam M.
    Mayadas, Tanya N.
    Warram, James H.
    Krolewski, Andrzej S.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (03): : 516 - 524
  • [28] Monocyte and macrophage heterogeneity
    Gordon, S
    Taylor, PR
    [J]. NATURE REVIEWS IMMUNOLOGY, 2005, 5 (12) : 953 - 964
  • [29] Exploring macrophage cell therapy on Diabetic Kidney Disease
    Guiteras, Roser
    Sola, Anna
    Flaquer, Maria
    Manonelles, Anna
    Hotter, Georgina
    Cruzado, Josep M.
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (02) : 841 - 851
  • [30] Macrophage Overexpressing NGAL Ameliorated Kidney Fibrosis in the UUO Mice Model
    Guiteras, Roser
    Sola, Anna
    Flaquer, Maria
    Hotter, Georgina
    Torras, Joan
    Maria Grinyo, Josep
    Maria Cruzado, Josep
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 42 (05) : 1945 - 1960